A photo of Marialena Mouzaki.

Medical Director, Advanced Nutrition Services

Associate Professor, UC Department of Pediatrics

513-636-4415

Board Certified

My Biography & Research

Additional Languages

Greek

Clinical Interests

Nutrition and specifically NAFLD; pediatric gastroenterology

Research Interests

Risk factors for the development of pediatric NAFLD and NASH

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Gastroenterology GI, Steatohepatitis

Research Divisions

Gastroenterology Hepatology and Nutrition

My Locations

My Education

MD: National and Kapodistrian Medical School of Athens, Greece, 2005.

Residency: General Pediatrics, Penn State Children's Hospital, Hershey, PA, 2009.

Clinical Fellowship: Hospital for Sick Children, Toronto, ON, Canada, 2010.

Clinical/Research Fellowship: Hospital for Sick Children, Toronto, ON, Canada, 2012.

Teaching Scholars Program: Hospital for Sick Children, Toronto, ON, Canada, 2016.

MSc: University of Toronto, Toronto, ON, Canada, 2012.

Certification: General Pediatrics, 2009; Pediatric Gastroenterology, 2013; National Board of Physician Nutrition Specialists, 2018.

 

My Publications

Underreporting of Hepatic Steatosis in Children: A Missed Opportunity for Early Detection. Okura, H; Yodoshi, T; Thapaliya, S; Trout, AT; Mouzaki, M. Journal of Pediatrics. 2021.

Microbiota-Driven Activation of Intrahepatic B Cells Aggravates Nonalcoholic Steatohepatitis through Innate and Adaptive Signaling. Barrow, F; Khan, S; Fredrickson, G; Wang, H; Dietsche, K; Parthiban, P; Robert, S; Kaiser, T; Winer, S; Herman, A; et al. Hepatology. 2021.

Evolving Role for Pharmacotherapy in NAFLD/NASH. Attia, SL; Softic, S; Mouzaki, M. Clinical and Translational Science. 2021; 14:11-19.

Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease. Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Xanthakos, SA; Mouzaki, M; Valentino, PL. Pediatric obesity. 2021; 16.

Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease?. Orkin, S; Yodoshi, T; Sun, Q; Fei, L; Meryum, S; Arce-Clachar, AC; Bramlage, K; Beck, AF; Mouzaki, M. Obesity Research. 2021; 29:171-176.

Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. Xanthakos, SA; Lavine, JE; Yates, KP; Schwimmer, JB; Molleston, JP; Rosenthal, P; Murray, KF; Vos, MB; Jain, AK; Scheimann, AO; et al. Gastroenterology. 2020; 159:1731-1751.e10.

Identifying Predictors of Response to Vitamin E for the Treatment of Pediatric Nonalcoholic Steatohepatitis. Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Su, W; Fei, L; Xanthakos, SA; Mouzaki, M. Journal of Parenteral and Enteral Nutrition. 2020; 44:1301-1307.

Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. Yodoshi, T; Orkin, S; Clachar, AA; Bramlage, K; Sun, Q; Fei, L; Beck, AF; Xanthakos, SA; Trout, AT; Mouzaki, M. Journal of Pediatrics. 2020; 223:93-99.e2.

Body Composition Using Air Displacement Plethysmography in Children With Inflammatory Bowel Disease. Dhaliwal, J; Martincevic, I; Williams, B; Frost, K; Uusoue, K; Arpino, V; Church, P; Walters, TD; Griffiths, AM; Mouzaki, M. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:52-58.

Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease. Yodoshi, T; Arce-Clachar, AC; Sun, Q; Fei, L; Bramlage, K; Xanthakos, SA; Flores, F; Mouzaki, M. Journal of Pediatrics. 2020; 222:127-133.